Surgeons have to balance between radical tumor resection and sparing healthy tissue.
The surgeon relies on visual and tactile feedback, which is not
always optimal. As a result, tumor tissue is often difficult to identify during surgery.
Bcon Medical is developing state-of-the-art navigation solutions to visualize the 3D anatomy of the target area and aid the localization of lesions and critical anatomical structures during oncologic surgery.
We utilize pre-operative diagnostic imaging data to visualize the 3D anatomy of the tumor and its surrounding vital structures during surgery.
We track the position of the patient and surgical instruments in real-time using state-of-the-art sensor technology.
Our system visualizes the position of the surgical instruments relative to the tumor and surrounding vital structures, all in one real-time view. This allows a higher percentage of radical tumor resections and spares healthy tissue.
A better understanding of the anatomy and tumor position during complex surgical procedures decreases procedure time, reduces cost and improves patient outcome.
The Bcon navigation system combines electromagnetic tracking of surgical instruments with state-of-the art real time visualization
of 3D anatomy and live ultrasound.
At the Netherlands Cancer Institute, researchers recognized the need to improve cancer surgery.
In more than 20% of the operated cancer patients, surgery is inadequate.
In these cases, either surgical resection margins still show tumor cells or too much healthy tissue is removed or damaged.
Tumor positive resection margins are a strong predictor for tumor recurrence, while damage to healthy tissue can result in long lasting complications such as urinary incontinence or sexual dysfunction. A surgeon has to balance between radical tumor resection and sparing healthy tissue.
Bcon Medical develops state-of-the-art navigation solutions to guide surgeons during complex surgical procedures. The first applications are advanced rectal and lymph node cancer surgery.
The company is a spin-out from the Netherlands Cancer Institute (NKI-AVL) in Amsterdam and is funded by private investors and two Venture Capital funds. It was founded in March 2021 by the Netherlands Cancer Institute, Theo Ruers, Nijs van der Vaart and Robin de Paus. We aim to make navigation solutions available and affordable for all surgical oncology hospitals.
I am glad I got away with it like this(Dutch)
Bcon Medical is funded by a group of private investors and two venture capital investors.